Influence of Cardiovascular and Metabolic Comorbidities on Sepsis Outcomes

Overview

This study evaluates the impact of cardiovascular and metabolic comorbidities on the severity and outcomes of hospital-acquired sepsis in ICU patients. Findings suggest that these comorbidities significantly influence inflammatory profiles and clinical outcomes in critically ill patients with sepsis.

Background

Sepsis is a major cause of mortality worldwide, accounting for 19.7% of global deaths. The condition is particularly severe in patients with pre-existing cardiovascular and metabolic disorders, which can exacerbate organ dysfunction and increase mortality rates. Understanding the relationship between these comorbidities and sepsis severity is crucial for improving patient management and outcomes in the ICU setting.

Data Highlights

This study included 459 participants, with 148 cases of sepsis and 311 controls, focusing on the association of comorbidities with sepsis severity and inflammatory markers.

Key Findings

• Sepsis was diagnosed based on Sepsis-3 criteria, indicating life-threatening organ dysfunction due to infection.
• Patients with cardiovascular and metabolic comorbidities exhibited altered inflammatory profiles, as measured by biomarkers such as PCT, IL-6, IL-10, and TNF-α.
• Septic shock, a severe form of sepsis, is associated with a mortality rate of 40-50%.
• Comorbidities significantly impact the inflammatory response and clinical outcomes in ICU patients with sepsis.
• Long-term complications post-sepsis include cognitive impairment and increased cardiovascular events.

Clinical Implications

Healthcare providers should consider the presence of cardiovascular and metabolic comorbidities when assessing sepsis severity and planning treatment strategies. Early identification and management of these comorbidities may improve outcomes for patients with sepsis in the ICU.

Conclusion

The study highlights the critical role of cardiovascular and metabolic comorbidities in influencing sepsis severity and outcomes, underscoring the need for tailored management strategies in affected patients.

References

1. Intensive Care Medicine, 2018 -- The Impact of ICU Hypotension on Mortality and Morbidity Among Septic Patients During Hospitalization
2. Intensive Care Medicine, 2010 -- The Relationship Between Sepsis and Acute Kidney Injury: Enhancing Care in Acute Renal Conditions
3. Infection, 2024 -- Exploring the Impact of Socioeconomic Status, Ethnicity, and Clinical Factors on Sepsis Mortality Rates
4. Critical Care, 2025 -- Association between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes
5. Surviving Sepsis Campaign Adult Guidelines | SCCM
6. Frontiers, 2026 -- Diabetes mellitus and mortality in patients admitted to ICU with sepsis: a meta-analysis
7. Medicina Clínica, 2025 -- Influence of comorbidities and chronic medications on ICU mortality in sepsis
8. Surviving Sepsis Campaign Adult Guidelines | SCCM
9. Frontiers | Diabetes mellitus and mortality in patients admitted to ICU with sepsis: a meta-analysis
10. Influence of comorbidities and chronic medications on ICU mortality in sepsis: A population-based cohort study of 12,095 patients | Medicina Clínica